首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
March 3, 2026
CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study
SS
Swathi Srikantan
XM
Xuan Ma
AA
Asif Alavi
See all
Key Points
CXCL9 levels indicate patient outcomes following allogeneic stem cell transplantation.
The study shows a significant correlation between CXCL9 and patient prognosis.
Observational analysis using a prospective cohort highlighted CXCL9 as a key inflammatory marker.
Understanding inflammatory markers like CXCL9 could improve post-transplant care strategies.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Srikantan et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7602cc6e9836116a2ca62
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.692
CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study | Synapse